Bangor Savings Bank Novartis Ag Transaction History

Bangor Savings Bank

$1.06 Billion
Q3 2024

A detailed history of Bangor Savings Bank transactions in Novartis Ag stock. As of the latest transaction made, Bangor Savings Bank holds 8,498 shares of NVS stock, worth $827,110. This represents 0.09% of its overall portfolio holdings.

Number of Shares

8,498

Previous 8,803 3.46%

Holding current value

$827,110

Previous $937,000 4.27%

% of portfolio

0.09%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$106.13 - $120.89 $32,369 - $36,871	-305 Reduced 3.46%	8,498 $977,000
Q2 2024 Jul 15, 2024	BUY	$92.57 - $107.37 $19,069 - $22,118	206 Added 2.4%	8,803 $937,000
Q1 2024 Apr 11, 2024	SELL	$95.27 - $108.47 $8,193 - $9,328	-86 Reduced 0.99%	8,597 $831,000
Q4 2023 Jan 16, 2024	BUY	$92.27 - $101.54 $47,334 - $52,090	513 Added 6.28%	8,683 $876,000
Q3 2023 Oct 24, 2023	BUY	$94.73 - $105.13 $23,398 - $25,967	247 Added 3.12%	8,170 $832,000
Q2 2023 Jul 07, 2023	BUY	$92.52 - $104.91 $43,947 - $49,832	475 Added 6.38%	7,923 $799,000
Q1 2023 Apr 06, 2023	SELL	$80.03 - $92.81 $72,667 - $84,271	-908 Reduced 10.87%	7,448 $685,000
Q4 2022 Jan 17, 2023	SELL	$75.55 - $92.52 $218,339 - $267,382	-2,890 Reduced 25.7%	8,356 $758,000
Q3 2022 Oct 12, 2022	BUY	$74.61 - $87.26 $13,280 - $15,532	178 Added 1.61%	11,246 $855,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $63,208 - $73,593	785 Added 7.63%	11,068 $936,000
Q1 2022 Apr 14, 2022	BUY	$80.11 - $90.62 $823,771 - $931,845	10,283 New	10,283 $902,000
Q4 2019 Jan 07, 2020	SELL	$84.35 - $95.37 $205,560 - $232,416	-2,437 Closed	0 $0
Q3 2019 Oct 07, 2019	BUY	$85.54 - $94.26 $208,460 - $229,711	2,437 New	2,437 $212,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bangor Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bangor Savings Bank with notifications on news.

Account

Bangor Savings Bank Novartis Ag Transaction History